GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
MEDIVATION INC (MDVN) [hlAlert]

Rating:
Sector Perform
MDVN

MEDIVATION INC (MDVN) rated Sector Perform with price target $40 by RBC Capital Mkts

Posted on: Friday,  Nov 6, 2015  4:25 PM ET by RBC Capital Mkts

MEDIVATION INC (NASDAQ: MDVN) rated
Sector Perform with price target $40 by RBC Capital Mkts.

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three medical needs: Alzheimer?s disease, Huntington?s disease and castration-resistant prostate cancer. The Company has formed separate subsidiaries to hold the product candidates it is developing. The Company?s subsidiary Medivation Neurology, Inc. holds its Dimebon technology, and its subsidiary Medivation Prostate Therapeutics, Inc. holds its MDV300 series technology.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/6/2015 4:25 PM Hold
None
40.00
as of 12/31/2010
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/30/2010 8:25 AM Hold
None
4.99
9/4/2008 8:25 AM Hold
None
14.81 17.00
8/12/2008 8:25 AM Hold
None
11.83 12.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy